![]() |
市場調查報告書
商品編碼
1383342
至 2030 年色素沉著過度治療市場預測:按類型、適應症、最終用戶和地區分類的全球分析Hyperpigmentation Treatment Market Forecasts to 2030 - Global Analysis By Type, Indication, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球色素沉著過度治療市場規模為 47.8 億美元,預計在預測期內將以 10.5% 的年複合成長率成長,到 2030 年達到 96.1 億美元。
色素沉澱一詞描述了由於黑色素(賦予皮膚顏色的色素)過多而導致的某些膚色區域變黑。許多因素都會對色素沉澱產生影響,包括荷爾蒙、紫外線照射、發炎和皮膚創傷。色素沉著過度治療的主要目標通常是均勻膚色並減少或去除多餘的色素。
根據 2022 年 4 月發布的美容整形外科國家資料庫,2021 年美國進行了 1,390,149 例化學換膚和水臉部護理等皮膚治療以及 431,485 例組合雷射治療。
隨著我們對皮膚健康認知的提高,人們正在採取預防措施來預防皮膚劣化。這包括採取預防措施,防止陽光引起的色素沉著,例如使用防曬油、穿著防護衣和留在陰涼處。實施全面的皮膚健康計劃提倡早期診斷和治療色素沉著相關疾病。當人們出現色素沉澱問題時,他們更有可能立即尋求專業建議和治療。對皮膚健康的認知培養了自我保健的文化。人們更有可能使用針對色素沉著和改善整體皮膚健康的皮膚護理程序。
顧客可能會因產品的負面影響而在心理和身體上遭受痛苦。這些包括燒燙傷、皮膚粗糙、過敏反應和色素沉著增加。對於接受治療的人來說,這些副作用可能會導致疼痛、不適和焦慮。當顧客經歷色素沉澱治療的負面副作用時,他們會對產品或服務失去信心。有負面經驗的人可能會對公司或服務產生懷疑,並且可能不願意尋求進一步的治療。嚴重的安全問題可能會導致產品召回、法律訴訟和法規行動,從而阻礙市場成長。
許多文化和地區都有不同的美麗標準,而乾淨、平衡、有光澤的皮膚往往就是其中之一。市場上產品和服務的可得性以及對色素沉著過度治療的需求可能會受到這些標準的顯著影響。美感和化妝品的選擇也受到文化美感的影響。提亮或淡化皮膚的護膚品和化妝品在某些地區很受歡迎,並且通常可以解決色素沉著問題。
摻雜或仿冒品可能含有危害顧客健康的危險或隱藏物質。這些產品可能會因皮膚發炎、過敏反應、燒燙傷或現有色素沉著疾病惡化而造成身體傷害和痛苦。購買劣質或仿冒品的顧客可能會蒙受經濟損失。顧客可能會忍不住購買這些產品,這些產品通常以低價出售,並承諾節省費用。然而,該產品後來可能被證明是有害的或無用的,這會因金錢損失而擾亂市場。
由於封鎖和安全問題,許多皮膚科診所和醫療水療中心在疫情爆發初期被迫暫時關閉或限制開放時間。結果,我的色素沉著治療預約被取消或推遲。病人不想去醫院,所以即使診所重新開放,也只有少數預約。一些患者決定延後擇期手術,包括色素沉著的治療。許多皮膚科醫生和皮膚護理專家已經開始提供虛擬諮詢和遠端醫療服務,作為適應不斷變化的情況的一種方式。雖然這使得患者照護具有一定的連續性,但也為需要面對面諮詢的治療方法帶來了挑戰。
由於雷射治療是色素沉澱的主流治療方法,並且被廣泛認為是治療各種類型色素沉著的最佳方法之一,因此雷射治療領域預計將出現良好的成長。雷射技術可瞄準並分解皮膚中多餘的黑色素,減少黑斑的出現,使膚色更加均勻。皮膚護理和雷射技術的科學不斷發展,有助於提供更安全、更有效的色素沉著雷射治療。
由於皮膚診所經常治療色素沉著,因此預計皮膚診所部分在預測期內將出現最高的年複合成長率。這些診所的皮膚科醫生和皮膚護理專家專門從事識別和管理各種皮膚狀況(包括色素沉著)的工作。根據評估,您的醫療保健專業人員將制定客製化的治療計劃,其中可以包括一種或多種治療方法。為了確保為患者提供最新、最有效的治療方法,我們皮膚科診所的皮膚護理專家隨時了解皮膚科和皮膚護理科學的最新進展。
根據預測,在預測期內,亞太地區預計將佔據最大的市場佔有率,因為西方的美麗理想、更高的可支配所得和不斷增加的皮膚護理知識是推動這一市場擴張的一些因素。過度暴露在陽光下是亞太地區色素沉澱的主要原因。因此,使用防曬油並保護自己免受陽光照射變得更加重要。此外,由於人們對皮膚科手術的興趣日益濃厚以及人們對皮膚健康的認知不斷提高,色素沉著過度市場正在擴大。
預計北美在預測期內的年複合成長率最高。這是因為皮膚科醫生和皮膚護理專業人員使用 IPL(強烈脈衝光)療法、Q 開關雷射、點陣雷射和其他雷射治療來瞄準和分解多餘的黑色素。北美擁有眾多皮膚護理設施、醫療水療中心和皮膚科診所,配備最先進的設備,並由具有治療色素沉著過度專業知識的合格專業人員組成。此外,太陽黑子、老年斑、黃褐斑和發炎後色素沉著 (PIH) 都是北美市場處理的色素沉澱型態。
According to Stratistics MRC, the Global Hyperpigmentation Treatment Market is accounted for $4.78 billion in 2023 and is expected to reach $9.61 billion by 2030 growing at a CAGR of 10.5% during the forecast period. The term "hyperpigmentation" describes the darkening of certain skin tone regions brought on by an excess of melanin, the pigment that gives skin its color. Numerous things, such as hormones, UV exposure, inflammation, and skin traumas, might contribute to it. The main goals of hyperpigmentation treatments are usually to level out the skin tone and minimize or remove excess pigment.
A greater understanding of skin health motivates people to adopt preventative measures against skin deterioration. This involves taking precautions against sun-induced hyperpigmentation, such as using sunscreen, dressing in protective clothes, and finding shade. The implementation of a comprehensive skin health plan advocates for the early diagnosis and treatment of disorders related to hyperpigmentation. People are more inclined to seek expert advice and treatment as soon as hyperpigmentation problems arise. A culture of self-care is fostered by awareness of skin health. People are more likely to follow regular skincare regimens that target hyperpigmentation and enhance the general health of their skin.
Customers may suffer psychologically and physically from a product's adverse impacts. There might be burns, skin irritation, allergic responses, or increasing hyperpigmentation. For those pursuing therapy, these side effects may cause pain, discomfort, and concern. Customers lose faith in a product or service when they suffer negative side effects from hyperpigmentation treatments. People who have had bad encounters may become skeptical of the company or service and be reluctant to seek out more care. Product recalls, legal action, and regulatory actions might result from serious safety concerns which hinder the market growth.
Many cultures and geographical areas have different standards of beauty, and clean, balanced, and glowing skins are frequently among them. The market's availability of goods and services, as well as the demand for hyperpigmentation treatments, may be significantly impacted by these criteria. Aesthetic and cosmetic choices are also influenced by cultural ideals of beauty. Products for skincare and cosmetics that brighten or lighten the skin are popular in specific areas and frequently address hyperpigmentation.
Products that are subpar or counterfeit may have dangerous or hidden substances that put customers' health at risk. These products have the potential to cause bodily injury and suffering due to skin irritations, allergic reactions, burns, or exacerbation of pre-existing hyperpigmentation disorders. Customers that purchase inferior or counterfeit goods may suffer financial damages. The promise of savings may entice customers to purchase these items, which are frequently sold at reduced costs. They could subsequently discover, though, that the product is hazardous or useless, in which case money would be lost thus impedes the market.
Due to lockdowns and safety concerns, numerous dermatological clinics and medical spas had to temporarily close or restrict their operational hours during the early phases of the epidemic. As a result, appointments for hyperpigmentation treatments were either cancelled or postponed. Patients were reluctant to visit hospitals, thus even once clinics reopened, fewer individuals were scheduled for appointments. Certain patients made the decision to postpone elective operations, including as treatments for hyperpigmentation. Many dermatologists and skincare specialists started providing virtual consultations and telemedicine services as a way to adjust to the changing circumstances. This made some continuity in patient care possible, but also presented difficulties for therapies that call for in-person consultations.
The laser treatment segment is estimated to have a lucrative growth, as the hyperpigmentation treatments is dominated by laser therapy, which is widely regarded as one of the best methods for treating different types of hyperpigmentation. Dark spots can be less noticeable and a more uniform skin tone can be attained by using laser technology to target and break down excess melanin in the skin. The science of skincare and laser technology is always evolving, which helps to provide safer and more efficient laser treatments for hyperpigmentation thus driving the market.
The skin clinics segment is anticipated to witness the highest CAGR growth during the forecast period, as Skin clinics frequently provide therapy for hyperpigmentation. Expert dermatologists and skincare specialists, who specialize in identifying and managing a variety of skin disorders, including hyperpigmentation, work in these clinics. Drawing on the evaluation, the medical professional will create a customized treatment program that can involve one or more therapy approaches. To guarantee that they are offering patients the most modern and efficient treatment alternatives, skincare specialists in skin clinics keep up to date on the most recent advancements in dermatology and skincare science.
Asia Pacific is projected to hold the largest market share during the forecast period due to western beauty ideals, more disposable wealth, and growing knowledge of skincare are some of the factors driving this expansion. Overexposure to the sun is a major cause of hyperpigmentation in the Asia Pacific area. As a result, using sunscreen creams and protecting oneself from the sun are now more important. Moreover, due to rising interest in dermatological procedures and rising awareness of skin health the market for hyperpigmentation market is growing.
North America is projected to have the highest CAGR over the forecast period, owing to Intense pulsed light (IPL) therapy, Q-switched lasers, fractional lasers, and other laser treatments are used by dermatologists and skincare specialists to target and breakdown excess melanin. North America is home to a sizable number of skincare facilities, medical spas, and dermatological clinics that are stocked with cutting-edge equipment and manned by qualified specialists with expertise in treating hyperpigmentation. In addition Sunspots, age spots, melasma, and post-inflammatory hyperpigmentation (PIH) are among the several forms of hyperpigmentation that are addressed in the North American market.
Some of the key players profiled in the Hyperpigmentation Treatment Market include: AbbVie Inc., Astellas Pharma Inc., Bausch Health Companies Inc, Candela Corporation, "DermaMed Solutions LLC, Dermavant Science Inc., Dr. Reddy's Laboratories Limited, Epionce, Galderma SA, Alvogen, Glenmark Pharmaceuticals Limited, Incyte Corporation, L'Oreal SA , Merz GmbH & Co. KGaA, Obagi Cosmeceuticals LLC, Pfizer Inc., Pierre Fabre Group, SkinCeuticals, Viatirs Inc. (Mylan N.V.) and Vital Esthetique
In October 2023, AbbVie announced that its Phase 2b study evaluating upadacitinib (RINVOQ®) in adults with non-segmental vitiligo (NSV) met the primary endpoint of percent change from baseline in the Facial Vitiligo Area Scoring Index (F-VASI) at week 24 with the 11 mg and 22 mg doses versus placebo.
In October 2023, Astellas Pharma Inc. and BioLabs Global, Inc. and Mitsui Fudosan announced that they have agreed on a tri-party memorandum of understanding to enhance the life science ecosystem in Tsukuba and Kashiwa-no-ha, Japan, world-renowned science hubs.
In September 2023, Bausch + Lomb Corporation a subsidiary of Bausch Health Companies Inc. announced that, in connection with the financing of its pending acquisition of XIIDRA® and certain other ophthalmology assets, Bausch + Lomb Escrow Corp.